COMP <GO>
ANIP vs NUVB // OPERATING MARGIN
ANI Pharmaceuticals Inc. (NASDAQ) VS. Nuvation Bio Inc. (Class A) (NYSE) • 15-METRIC TALLY: ANIP 9
— NUVB 1
▲ OPERATING MARGIN LEADER: ANIP
LAST: $72.00 (-1.59%) • MKT CAP: $1.68B
operating-margins
12.60%
LAST: $4.76 (-0.21%) • MKT CAP: $1.67B
operating-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANIP VS. NUVB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ANIP | NUVB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.00% | -35.00% | +51.00 | ANIP | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.7x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 10.20% | -10.35% | +20.55 | ANIP | /fcf-yield <GO> |
| Operating Margin ACTIVE | 12.60% | -60.00% | +72.60 | ANIP | /operating-margins <GO> |
| Net Profit Margin | 8.80% | -60.00% | +68.80 | ANIP | /net-margins <GO> |
| Revenue Growth (YoY) | 43.80% | 180.00% | -136.20 | NUVB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.07% | 0.00% | +0.07 | ANIP | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.36 | 0.76 | +1.60 | ANIP | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | ANIP | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.7 | 42.6 | +9.10 | ANIP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.1x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.68B | $1.67B | $4.9M | ANIP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ANIP REV | NUVB REV | ANIP GROSS % | NUVB GROSS % | ANIP FCF | NUVB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $883.4M | $62.9M | — | — | $171.4M | -$173.4M |
| FY 2024 | $614.4M | $7.9M | — | 10.1% | $47.8M | -$130.4M |
| FY 2023 | $486.8M | $0 | — | — | $119.0M | -$68.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANIP // BETA —
NUVB // BETA —